Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Modulatory Effect of the Euro-Lupus Low-Dose Intravenous Cyclophosphamide Regimen on Circulating Immune Cells in Systemic Lupus Erythematosus

G. Gabcova, P. Horak, Z. Mikulkova, M. Skacelova, S. Zehnalova, A. Smrzova, A. Petrackova, F. Mrazek, E. Kriegova,

. 2019 ; 67 (6) : 415-425. [pub] 20191016

Language English Country Switzerland

Document type Journal Article

Grant support
FNOL Ministerstvo Zdravotnictví České Republiky
00098892 Ministerstvo Zdravotnictví České Republiky
IGA_LF_2019_006 Univerzita Palackého v Olomouci
IGA_LF_2019_014 Univerzita Palackého v Olomouci

A Euro-Lupus regimen of low-dose intravenous cyclophosphamide (CFA) is commonly used to treat severe organ manifestations of systemic lupus erythematosus (SLE), particularly lupus nephritis (LN). There are no data on the distributions and dynamics of immune cell populations in patients with various treatment outcomes. The circulating immune cells of 11 female SLE patients were assessed before and after Euro-Lupus regimen (cumulative dose of 3000 mg CFA) by flow cytometry together with those of 16 healthy women. A subanalysis was performed in LN patients who achieved complete remission (CR; n = 3), partial remission (PR; n = 4), and no response (NR; n = 2). In SLE, the Euro-Lupus regimen decreased the percentage and absolute count of B cells; increased the percentage of CD8+ T cells, T regulatory cells, neutrophils, and monocyte subsets; and activated T and NK cells compared to healthy controls (P < 0.050). Patients with LN achieving CR had significantly lower proportions of CD27+ B memory cells compared to poor responders (PR/NR, P = 0.035). The post-treatment percentages and absolute numbers of B cells, T cells, NK cells, monocytes, and neutrophils showed high inter-individual variability with no association with treatment outcome. Our pilot study revealed the dynamics of changes in immune cell populations in SLE patients during a Euro-Lupus regimen, mainly the lowering of B cells. In LN patients who achieved CR, a lower proportion of CD27+ B memory cells was evident compared to poor responders (PR/NR). Further studies on usefulness of monitoring immune cells for treatment response prediction on larger cohorts are needed.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20005789
003      
CZ-PrNML
005      
20200526095724.0
007      
ta
008      
200511s2019 sz f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00005-019-00563-4 $2 doi
035    __
$a (PubMed)31620814
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Gabcova, Gabriela $u Department of Immunology, Faculty of Medicine and Dentistry, Palacký University Olomouc, University Hospital Olomouc, Hnevotinska 3, 775 15, Olomouc, Czech Republic.
245    10
$a Modulatory Effect of the Euro-Lupus Low-Dose Intravenous Cyclophosphamide Regimen on Circulating Immune Cells in Systemic Lupus Erythematosus / $c G. Gabcova, P. Horak, Z. Mikulkova, M. Skacelova, S. Zehnalova, A. Smrzova, A. Petrackova, F. Mrazek, E. Kriegova,
520    9_
$a A Euro-Lupus regimen of low-dose intravenous cyclophosphamide (CFA) is commonly used to treat severe organ manifestations of systemic lupus erythematosus (SLE), particularly lupus nephritis (LN). There are no data on the distributions and dynamics of immune cell populations in patients with various treatment outcomes. The circulating immune cells of 11 female SLE patients were assessed before and after Euro-Lupus regimen (cumulative dose of 3000 mg CFA) by flow cytometry together with those of 16 healthy women. A subanalysis was performed in LN patients who achieved complete remission (CR; n = 3), partial remission (PR; n = 4), and no response (NR; n = 2). In SLE, the Euro-Lupus regimen decreased the percentage and absolute count of B cells; increased the percentage of CD8+ T cells, T regulatory cells, neutrophils, and monocyte subsets; and activated T and NK cells compared to healthy controls (P < 0.050). Patients with LN achieving CR had significantly lower proportions of CD27+ B memory cells compared to poor responders (PR/NR, P = 0.035). The post-treatment percentages and absolute numbers of B cells, T cells, NK cells, monocytes, and neutrophils showed high inter-individual variability with no association with treatment outcome. Our pilot study revealed the dynamics of changes in immune cell populations in SLE patients during a Euro-Lupus regimen, mainly the lowering of B cells. In LN patients who achieved CR, a lower proportion of CD27+ B memory cells was evident compared to poor responders (PR/NR). Further studies on usefulness of monitoring immune cells for treatment response prediction on larger cohorts are needed.
650    _2
$a intravenózní podání $7 D061605
650    _2
$a dospělí $7 D000328
650    _2
$a krevní oběh $7 D001775
650    _2
$a klinické protokoly $7 D002985
650    _2
$a kohortové studie $7 D015331
650    _2
$a cyklofosfamid $x terapeutické užití $7 D003520
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a průtoková cytometrie $7 D005434
650    _2
$a lidé $7 D006801
650    _2
$a imunologická paměť $7 D007156
650    _2
$a imunomodulace $7 D056747
650    _2
$a imunosupresiva $x terapeutické užití $7 D007166
650    _2
$a systémový lupus erythematodes $x farmakoterapie $7 D008180
650    _2
$a nefritida při lupus erythematodes $x farmakoterapie $7 D008181
650    _2
$a lymfocyty $x účinky léků $x imunologie $7 D008214
650    _2
$a lidé středního věku $7 D008875
650    _2
$a indukce remise $7 D012074
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
700    1_
$a Horak, Pavel $u Department of Internal Medicine III-Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacký University Olomouc, University Hospital Olomouc, Olomouc, Czech Republic.
700    1_
$a Mikulkova, Zuzana $u Department of Immunology, Faculty of Medicine and Dentistry, Palacký University Olomouc, University Hospital Olomouc, Hnevotinska 3, 775 15, Olomouc, Czech Republic.
700    1_
$a Skacelova, Martina $u Department of Internal Medicine III-Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacký University Olomouc, University Hospital Olomouc, Olomouc, Czech Republic.
700    1_
$a Zehnalova, Sarka $u Department of Computer Science, Faculty of Electrical Engineering and Computer Science, VSB-Technical University of Ostrava, Ostrava, Czech Republic.
700    1_
$a Smrzova, Andrea $u Department of Internal Medicine III-Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacký University Olomouc, University Hospital Olomouc, Olomouc, Czech Republic.
700    1_
$a Petrackova, Anna $u Department of Immunology, Faculty of Medicine and Dentistry, Palacký University Olomouc, University Hospital Olomouc, Hnevotinska 3, 775 15, Olomouc, Czech Republic.
700    1_
$a Mrazek, Frantisek $u Department of Immunology, Faculty of Medicine and Dentistry, Palacký University Olomouc, University Hospital Olomouc, Hnevotinska 3, 775 15, Olomouc, Czech Republic.
700    1_
$a Kriegova, Eva $u Department of Immunology, Faculty of Medicine and Dentistry, Palacký University Olomouc, University Hospital Olomouc, Hnevotinska 3, 775 15, Olomouc, Czech Republic. eva.kriegova@email.cz.
773    0_
$w MED00000581 $t Archivum immunologiae et therapiae experimentalis $x 1661-4917 $g Roč. 67, č. 6 (2019), s. 415-425
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31620814 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20200526095720 $b ABA008
999    __
$a ok $b bmc $g 1524647 $s 1095845
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 67 $c 6 $d 415-425 $e 20191016 $i 1661-4917 $m Archivum Immunologiae et Therapiae Experimentalis $n Arch Immunol Ther Exp (Warsz) $x MED00000581
GRA    __
$a FNOL $p Ministerstvo Zdravotnictví České Republiky
GRA    __
$a 00098892 $p Ministerstvo Zdravotnictví České Republiky
GRA    __
$a IGA_LF_2019_006 $p Univerzita Palackého v Olomouci
GRA    __
$a IGA_LF_2019_014 $p Univerzita Palackého v Olomouci
LZP    __
$a Pubmed-20200511

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...